期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
对接受维生素A治疗的视网膜色素变性患者加用二十二碳六烯酸效果的进一步分析:亚群分析
1
作者 berson E.L. rosner b. +1 位作者 Sandberg M.A. 张磊 《世界核心医学期刊文摘(眼科学分册)》 2005年第2期17-18,共2页
Objective: To determine whether docosahexaenoic acid will slow the course of r etinal degeneration in subgroups of patients with retinitis pigmentosa who are r eceiving vitamin A. Design: Acohort of 208 patients with ... Objective: To determine whether docosahexaenoic acid will slow the course of r etinal degeneration in subgroups of patients with retinitis pigmentosa who are r eceiving vitamin A. Design: Acohort of 208 patients with retinitis pigmentosa, a ged 18 to 55 years, were randomly assigned to 1200 mg of docosahexaenoic acid pl us 15000 IU/d of vitamin A given as retinyl palmitate (DHA +A group) or control fatty acid plus 15000 IU/d of vitamin A (control +A group) and followed up ove r 4 years. Seventy percent of the patients in each group were taking vitamin A, 15000 IU/d, prior to entry. We compared rates of decline in ocular function in t he DHA +A vs control +A groups among the subgroups defined by use or nonuse of vitamin A prior to entry. We also determined whether decline in ocular function was related to red blood cell phosphatidylethanolamine docosahexaenoic acid lev el, dietary ω-3 fatty acid intake, or duration of vitamin A use. Main outcome measures were Humphrey Field Analyzer visual field sensitivity, 30-Hz electrore tinogram amplitude, and visual acuity. Results: Among patients not taking vitami n A prior to entry, those in the DHA +A group had a slower decline in field sen sitivity and electroretinogram amplitude than those in the control +A group ove r the first 2 years (P=.01 and P=.03, respectively); these differences were not observed in years 3 and 4 of follow-up or among patients taking vitamin A prior to entry. In the entire cohort, red blood cell phosphatidylethanolamine docosah exaenoic acid level was inversely related to rate of decline in total field sens itivity over 4 years (test for trend, P=0.05). This was particularly evident ove r the first 2 years among those not on vitamin A prior to entry (test for trend, P=0.003). In the entire control +A group, dietary ω-3 fatty acid intake was inversely related to loss of total field sensitivity over 4 years (intake,< 0.20 vs ≥0.20 g/d; P= 0.02). The duration of vitamin A supplementation prior to ent ry was inversely related to rate of decline in electroretinogram amplitude (P=.0 08). Conclusions: For patients with retinitis pigmentosa beginning vitamin A the rapy, addition of docosahexaenoic acid, 1200 mg/d, slowed the course of disease for 2 years. Among patients on vitamin A for at least 2 years, a diet rich in ω -3 fatty acids (≥0.20 g/d) slowed the decline in visual field sensitivity. 展开更多
关键词 视网膜色素变性 二十二碳六烯酸 群分析 视网膜电图 视功能 棕榈酸视黄酯 磷脂酰乙醇胺 负相关 趋势检验 队列研究
下载PDF
维生素A加用二十二碳六烯酸治疗视网膜色素变性患者的临床试验研究
2
作者 berson E.L. rosner b. +1 位作者 Sandberg M.A. 张磊 《世界核心医学期刊文摘(眼科学分册)》 2005年第2期16-17,共2页
Objective: To determine whether a therapeutic dose of docosahexaenoic acid (DH A), an ω-3 fatty acid, will slow the course of retinal degeneration in adult p atients with retinitis pigmentosa who are also receiving v... Objective: To determine whether a therapeutic dose of docosahexaenoic acid (DH A), an ω-3 fatty acid, will slow the course of retinal degeneration in adult p atients with retinitis pigmentosa who are also receiving vitamin A. Design: Rand omized, controlled, double-masked trial of 221 patients, aged 18 to 55 years, e valuated over a 4-year interval. Patients were given either 1200 mg/d of docosa hexaenoic acid or control capsules. All were given 15000 IU/d of vitamin A (give n as retinyl palmitate). Randomization considered genetic type and baseline diet ary ω-3 fatty acid intake. Main Outcome Measures: The primary outcome measure was the total point score for the 30-2 program of the Humphrey field analyzer; secondary outcome measures were the total point score for the 30-2 and 30/60-1 programs combined, 30-Hz electroretinogram amplitude, and Early Treatment Diab etic Rentinopathy Study visual acuity. Results: No significant differences in de cline in ocular function were found between the docosahexaenoic acid plus vitami n A (DHA +A) group and control plus vitamin A (control +A)-group over a 4-ye ar interval among all 221 randomized patients or among the 208 patients who comp leted all 4 follow-up visits. The mean annual rate of loss of sensitivity for the Humphrey Field Analyzer 30-2 programwas 37 dB for the DHA +A group and 38 dB for the control +A group (P=0.88). For the Humphrey Field Analyzer 30-2 and 30/60-1 programs combined, the mean annual rates of loss of field sensitivity were 57 dB for the DHA +A group and 60 dB (P=0.73) for contro l +A group. No toxic adverse effects were observed. No significant differences by treatment group assignment were observed within genetic types or within the c ategory of baseline ω-3 fatty acid intake. Conclusion: In patients assigned to receive 15000 IU/d of vitamin A, this randomized trial showed that 1200 mg/d of docosahexaenoic acid supplementation over a 4-year interval did not, on averag e, slow the course of disease in patients with retinitis pigmentosa. 展开更多
关键词 视网膜色素变性 临床试验研究 二十二碳六烯酸 视网膜电图 视野计 棕榈酸视黄酯 联合分析 视功能 视力检查 下降值
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部